Equity Overview
Price & Market Data
Price: $2.96
Daily Change: +$0.04 / 1.35%
Daily Range: $2.82 - $3.04
Market Cap: $25,450,672
Daily Volume: 33,982
Performance Metrics
1 Week: 17.00%
1 Month: 5.71%
3 Months: 28.70%
6 Months: 9.06%
1 Year: -7.79%
YTD: -0.67%
Company Details
Employees: 26
Sector: Health technology
Industry: Pharmaceuticals: major
Country:
Details
Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product is certepetide, which is in Phase 2 clinical studies for the treatment of solid tumors, such as metastatic pancreatic ductal adenocarcinoma, cholangiocarcinoma, appendiceal cancer, and colon cancer and glioblastoma multiforme in combination with a range of anti-cancer regimens. The company was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.